COMMUNIQUÉ DE PRESSE publié le 01/02/2023 à 14:30, il y a 3 années 3 mois Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
COMMUNIQUÉ DE PRESSE publié le 30/01/2023 à 14:30, il y a 3 années 3 mois Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
COMMUNIQUÉ DE PRESSE publié le 27/01/2023 à 22:15, il y a 3 années 3 mois Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
COMMUNIQUÉ DE PRESSE publié le 26/01/2023 à 14:30, il y a 3 années 3 mois Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
COMMUNIQUÉ DE PRESSE publié le 25/01/2023 à 14:30, il y a 3 années 3 mois Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
COMMUNIQUÉ DE PRESSE publié le 23/01/2023 à 14:30, il y a 3 années 3 mois Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
COMMUNIQUÉ DE PRESSE publié le 20/01/2023 à 18:45, il y a 3 années 4 mois Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
COMMUNIQUÉ DE PRESSE publié le 20/01/2023 à 14:30, il y a 3 années 4 mois Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
COMMUNIQUÉ DE PRESSE publié le 12/01/2023 à 01:10, il y a 3 années 4 mois REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Der
COMMUNIQUÉ DE PRESSE publié le 11/01/2023 à 14:30, il y a 3 années 4 mois Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board
Publié le 20/05/2026 à 18:00, il y a 7 heures 55 minutes General shareholders meeting of 20 May, 2026
Publié le 20/05/2026 à 18:00, il y a 7 heures 55 minutes General shareholders meeting of 20 May, 2026
Publié le 20/05/2026 à 17:45, il y a 8 heures 10 minutes Report on share repurchases from 13 to 19 May 2026
Publié le 21/05/2026 à 01:25, il y a 30 minutes Mongolia Growth Group Announces Completion of Arrangement and Changes to the Board and Executive Leadership
Publié le 20/05/2026 à 22:40, il y a 3 heures 15 minutes Jaguar Health Reports First Quarter 2026 Financials
Publié le 20/05/2026 à 22:15, il y a 3 heures 40 minutes Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Publié le 20/05/2026 à 15:28, il y a 10 heures 27 minutes Sarama Resources Announces Private Equity Placement of A$1.5m
Publié le 20/05/2026 à 15:01, il y a 10 heures 54 minutes Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Publié le 20/05/2026 à 22:00, il y a 3 heures 55 minutes Nebius and Bloom Energy partner to power AI infrastructure build-out
Publié le 20/05/2026 à 21:35, il y a 4 heures 20 minutes IGEL and Zscaler Release Healthcare Security Blueprints for Distributed Care Delivery
Publié le 20/05/2026 à 20:15, il y a 5 heures 40 minutes EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Publié le 20/05/2026 à 19:34, il y a 6 heures 21 minutes CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Publié le 20/05/2026 à 19:34, il y a 6 heures 21 minutes EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26
